Articles > Popular publications > Business Wire press releases > April-June 2000 > Wednesday, May 10

Article: DUSA Pharmaceuticals Reports First Quarter Corporate Highlights and Financial Results.

Article from:
Business Wire
Article date:
May 10, 2000
Copyright

Health/Medical Writers

WILMINGTON, Mass.--(BW HEALTHWIRE)--May 10, 2000

DUSA Pharmaceuticals, Inc. (NASDAQ/NMS:DUSA) reported today its corporate highlights and financial results for the first quarter ended March 31, 2000.

Corporate Highlights

DUSA has been working closely with its dermatology marketing partner, Schering AG Germany and its US affiliate, Berlex Laboratories, Inc. in preparation for the upcoming launch of DUSA's Levulan(R) (aminolevulinic acid HCl) Kerastick(TM) with Photodynamic Therapy (PDT) for the treatment of actinic keratoses (AKs) of the face and scalp in the US. During the quarter, DUSA continued the ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Schering AG: MabCampath(TM) Approved in ...
PR Newswire;  July 12, 2001 ;     700+ words ... ... PRNewswire/ -- Schering AG (FSE: SCH; NYSE ... licensed MabCampath(TM) (alemtuzumab ... MabCampath(TM) is another cornerstone ... Executive Board of Schering AG responsible for research ... lymphocytes. MabCampath(TM) binds to CD52 ... affected organs. Schering AG is a ...

Article: Delsys Enters Into An Agreement With Schering AG to ...
PR Newswire;  July 24, 2001 ;     700+ words ... ... today an agreement with Schering AG (NYSE: SHR; FSE: SCH ... will utilize its Accudep(TM) technology to formulate ... dosage form of a proprietary Schering AG hormone product. Terms ... disclosed. The Accudep(TM) technology is a highly ...

Article: Ferghana Partners Advised Schering AG On ...
PR Newswire;  June 6, 2002 ;     700+ words ...NEW YORK -- Schering AG of Berlin, Germany, has completed ... will develop and market Refludan(TM) outside of North America. Schering ... to develop and market Refludan(TM) in Canada and the U.S. Refludan(TM) is currently a treatment for ...

Article: Schering AG Acquires Japan and Asia Marketing ...
PR Newswire;  February 5, 2003 ;     700+ words ...Schering AG, Germany (FSE ... biopharmaceutical company ILEX(TM) Oncology, Inc ... member of the Schering AG Group. In Europe ... name of MabCampath(TM). The newly announced ... named MabCampath(TM). Schering AG is a research-based ...

Article: Myriad Genetics Expands ProNet Collaboration With Schering ...
PR Newswire;  October 26, 1999 ;     700+ words ... ... expanded its ProNet(TM) collaboration with Schering AG, Germany, into the heart ... of our partnership with Schering AG on ProNet(TM) and our internal drug ... developed using ProNet(TM). Initially, Schering AG used the ProNet(TM ...

Article: Schering AG Acquires Japan and Asia Marketing ...
Business Wire;  February 5, 2003 ;     700+ words ... ... Feb. 5, 2003 Schering AG, Germany (FSE ... SHR) and ILEX(tm) Oncology Inc ... were granted to Schering AG in 1999. CAMPATH ... member of the Schering AG Group. In Europe ... name of MABCAMPATH(tm). The newly announced ...

Article: PRAECIS PHARMACEUTICALS INCORPORATED Announces Agreement with ...
Business Wire;  April 28, 2004 ;     700+ words ... ... distribution agreement with Schering AG, of Berlin, Germany ... commercialization of Plenaxis(TM) in the field of ... extremely pleased to have Schering AG as our partner as ... commercialization of Plenaxis(TM) in these territories. Schering AG has significant experience ...

Article: Schering AG: Strong Performance in 2001 Paves Way ...
PR Newswire;  February 5, 2002 ;     700+ words ... ... Preliminary results of Schering AG's (FSE: SCH) 2001 ... the Executive Board of Schering AG. "Our successful launches ... Campath(R)/MabCampath(TM) are key components for ... the Executive Board of Schering AG. "Enhanced U.S. marketing ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives